August 28, 2015.
Technology
Latest News
Advertisement
Advertisement
Pharmaceutical Executive
GSK announces plan to divest its rights in ofatumumab for auto-immune indications for up to $1 billion.
Pharmaceutical Executive
August 27, 2015.
Pharmaceutical Executive
August 27, 2015.
August 26, 2015.
August 26, 2015.
August 25, 2015.
Pharmaceutical Executive
Manufacturers seek gradual rollout of more targeted FDA quality metrics program.
August 24, 2015.
Pharmaceutical Executive
August 20, 2015.
Pharmaceutical Executive
August 20, 2015.
August 18, 2015.
August 19, 2015.
August 19, 2015.
August 18, 2015.
August 14, 2015.
August 14, 2015.
August 13, 2015.
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Marty Makary Out as FDA Commissioner: Report
3
The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff
4
From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box
5